WIRE — Clinically meaningful improvements in skin symptoms reported as early as week 4 and sustained over the 48-week study period  Data presented at the 6th World Congress of Cutaneous Lymphomas meeting in Montreal, Canada PRINCETON, N.J., June 29, 2026 (GLOBE NEWSWIRE) Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), ... Read more The post New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome appeared first on Namibia News Digest.

"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."

This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.